Abstract
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare, but well-defined monogenic disorder that is caused by mutations in the autoimmune regulator (AIRE) gene on chromosome 21q22.3. Patients most often suffer from loss of endocrine function in the parathyroid and adrenal glands but may also develop Type 1 diabetes, thyroid disease or hypogonadism. The disease may therefore serve as a model for sporadic endocrine autoimmunity and help to develop new screening and prevention methods. To date at least 46 mutations of AIRE have been identified in affected individuals. Little is known about heterozygosity states but patients with the more prevalent isolated autoimmune endocrinopathies such as Type 1 diabetes, Hashimoto’s thyroiditis, Graves’ or Addison’s disease do not have any of the common mutations. This does not rule out AIRE to be affected either by so far unknown or regulatory variants. The recent characterization of AIRE knockout mice with similar immune pathological findings compared to the human setting will help to elucidate endocrine autoimmunity.
Similar content being viewed by others
References
Ahonen P. Autoimmune polyendocrinopathy-candidiosis-ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin. Genet. 1985, 27: 535–542.
Ahonen P., Myllärniemi S., Sipilä I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 1990, 322: 1829–1836.
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm. Metab. Res. 1996, 28: 353–356.
Betterle C., Greggio N.A., Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J. Clin. Endocrinol. Metab. 1998, 83: 1049–1055.
Velloso L.A., Winqvist O., Gustafsson J., Kampe O., Karlsson F.A. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Diabetologia 1994, 37: 61–69.
Tuomi T., Bjorses P., Falorni A., et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 1996, 81: 1488–1494.
Husebye E.S., Gebre-Medhin G., Tuomi T., et al. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 1997, 82: 147–150.
Bjorses P., Aaltonen J., Horelli-Kuitunen N., Yaspo M.L., Peltonen L. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 1998, 7: 1547–1553.
Peterson P., Nagamine K., Scott H., et al. APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol. Today 1998, 19: 384–386.
Rosatelli M.C., Meloni A., Meloni A., et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum. Genet. 1998, 103: 428–434.
Scott H.S., Heino M., Peterson P., et al. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol. Endocrinol. 1998, 12: 1112–1119.
Klemetti P., Bjorses P., Tuomi T., et al. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Clin. Exp. Immunol. 2000, 119: 419–425.
Uibo R., Aavik E., Peterson P., et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J. Clin. Endocrinol. Metab. 1994, 78: 323–328.
Ekwall O., Hedstrand H., Grimelius L., et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998, 352: 279–283.
Zlotogora J., Shapiro M.S. Polyglandular autoimmune syndrome type I among Iranian Jews. J. Med. Genet. 1992, 29: 824–826.
Bjorses P., Halonen M., Palvimo J.J., et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am. J. Hum. Genet. 2000, 66: 378–392.
Weetman A.P. Autoimmunity and endocrinology. Exp. Clin. Endocrinol. Diabetes 1999, 107: S63–S66.
Meloni A., Perniola R., Faa V., Corvaglia E., Cao A., Rosatelli M.C. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J. Clin. Endocrinol. Metab. 2002, 87: 841–846.
Aaltonen J., Horelli-Kuitunen N., Fan J.B., et al. High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res. 1997, 7: 820–829.
Chen Q.Y., Lan M.S., She J.X., Maclaren N.K. The gene responsible for autoimmune polyglandular syndrome type 1 maps to chromosome 21q22.3 in US patients. J. Autoimmun. 1998, 11: 177–183.
An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat. Genet. 1997, 17: 399–403.
Nagamine K., Peterson P., Scott H.S. et al. Positional cloning of the APECED gene. Nat. Genet. 1997, 17: 393–398.
Pitkänen J., Doucas V., Sternsdorf T., et al. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J. Biol. Chem. 2000, 275: 16802–16809.
Heino M., Peterson P., Kudoh J., et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem. Biophys. Res. Commun. 1999, 257: 821–825.
Pearce S.H., Cheetham T., Imrie H., et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am. J. Hum. Genet. 1998, 63: 1675–1684.
Wang C.Y., Davoodi-Semiromi A., Huang W., Connor E., Shi J.D., She J.X. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum. Genet. 1998, 103: 681–685.
Gibson T.J., Ramu C., Gemund C., Aasland R. The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor. Trends Biochem. Sci. 1998, 23: 242–244.
Ward L., Paquette J., Seidman E., et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J. Clin. Endocrinol. Metab. 1999, 84: 844–852.
Heino M., Scott H.S., Chen Q., et al. Mutation analyses of North American APS-1 patients. Hum. Mutat. 1999, 13: 69–74.
Ishii T., Suzuki Y., Ando N., Matsuo N., Ogata T. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 2000, 85: 2922–2926.
Ahonen P., Koskimies S., Lokki M.L., Tiilikainen A., Perheentupa J. The expression of autoimmune polyglandular disease type I appears associated with several HLAA antigens but not with HLA-DR. J. Clin. Endocrinol. Metab. 1988, 66: 1152–1157.
Hattori M., Fujiyama A., Taylor T.D., et al. The DNA sequence of human chromosome 21. Nature 2000, 405: 311–319.
Nithiyananthan R., Heward J.M., Allahabadia A., Barnett A.H., Franklyn J.A., Gough S.C. A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association. J. Clin. Endocrinol. Metab. 2000, 85: 1320–1322.
Vaidya B., Imrie H., Geatch D.R., et al. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison’s disease. J. Clin. Endocrinol. Metab. 2000, 85: 688–691.
Meyer G., Donner H., Herwig J., Bohles H., Usadel K.H., Badenhoop K. Screening for an AIRE-1 mutation in patients with Addison’s disease, type 1 diabetes, Graves’ disease and Hashimoto’s thyroiditis as well as in APECED syndrome. Clin. Endocrinol. (Oxf.) 2001, 54: 335–338.
Pastinen T., Raitio M., Lindroos K., Tainola P., Peltonen L., Syvänen A.C. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res. 2000, 10: 1031–1042.
Peltonen L., Jalanko A., Varilo T. Molecular genetics of the Finnish disease heritage. Hum. Mol. Genet. 1999, 8: 1913–1923.
Pitkänen J., Vahamurto P., Krohn K., Peterson P. Subcellular localization of the autoimmune regulator protein, characterization of nuclear targeting and transcriptional activation domain. J. Biol. Chem. 2001, 276: 19597–19602.
Otonkoski T., Roivainen M., Vaarala O., et al. Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000, 43: 1235–1238.
Heino M., Peterson P., Sillanpää N., et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur. J. Immunol. 2000, 30: 1884–1893.
Zuklys S., Balciunaite G., Agarwal A., Fasler-Kan E., Palmer E., Hollander G.A. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J. Immunol. 2000, 165: 1976–1983.
Ramsey C., Winqvist O., Puhakka L., et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 2002, 11: 397–409.
Gylling M., Tuomi T., Bjorses P., et al. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Clin. Endocrinol. Metab. 2000, 85: 4434–4440.
Cihakova D., Trebusak K., Heino M., et al. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum. Mutat. 2001, 18: 225–232.
Heino M., Peterson P., Kudoh J., et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum. Mutat. 2001, 18: 205–211.
Cetani F., Barbesino G., Borsari S., et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 2001, 86: 4747–4752.
Vogel A., Liermann H., Harms A., Strassburg C.P., Manns M.P., Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology 2001, 33: 1047–1052.
Saugier-Veber P., Drouot N., Wolf L.M., Kuhn J.M., Frebourg T., Lefebvre H. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Eur. J. Endocrinol. 2001, 144: 347–351.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, G., Badenhoop, K. Autoimmune regulator (AIRE) gene on chromosome 21: Implications for autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and more common manifestations of endocrine autoimmunity. J Endocrinol Invest 25, 804–811 (2002). https://doi.org/10.1007/BF03345516
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345516